These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26891796)

  • 1. Head to head comparison of the propensity score and the high-dimensional propensity score matching methods.
    Guertin JR; Rahme E; Dormuth CR; LeLorier J
    BMC Med Res Methodol; 2016 Feb; 16():22. PubMed ID: 26891796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the high-dimensional propensity score in adjusting for unmeasured confounders.
    Guertin JR; Rahme E; LeLorier J
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1497-1505. PubMed ID: 27578249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions.
    Neugebauer R; Schmittdiel JA; Zhu Z; Rassen JA; Seeger JD; Schneeweiss S
    Stat Med; 2015 Feb; 34(5):753-81. PubMed ID: 25488047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Propensity-score-based Fine Stratification Approach for Confounding Adjustment When Exposure Is Infrequent.
    Desai RJ; Rothman KJ; Bateman BT; Hernandez-Diaz S; Huybrechts KF
    Epidemiology; 2017 Mar; 28(2):249-257. PubMed ID: 27922533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications.
    Garbe E; Kloss S; Suling M; Pigeot I; Schneeweiss S
    Eur J Clin Pharmacol; 2013 Mar; 69(3):549-57. PubMed ID: 22763756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies with many covariates and few outcomes: selecting covariates and implementing propensity-score-based confounding adjustments.
    Patorno E; Glynn RJ; Hernández-Díaz S; Liu J; Schneeweiss S
    Epidemiology; 2014 Mar; 25(2):268-78. PubMed ID: 24487209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An application of propensity score matching using claims data.
    Seeger JD; Williams PL; Walker AM
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):465-76. PubMed ID: 15651087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the High-dimensional Propensity Score in a Nordic Healthcare Model.
    Hallas J; Pottegård A
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):312-317. PubMed ID: 27889951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of statin use with cataracts: a propensity score-matched analysis.
    Leuschen J; Mortensen EM; Frei CR; Mansi EA; Panday V; Mansi I
    JAMA Ophthalmol; 2013 Nov; 131(11):1427-34. PubMed ID: 24052188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the impact of propensity score estimation and implementation on covariate balance and confounding control within and across important subgroups in comparative effectiveness research.
    Girman CJ; Gokhale M; Kou TD; Brodovicz KG; Wyss R; Stürmer T
    Med Care; 2014 Mar; 52(3):280-7. PubMed ID: 24374422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable Selection for Confounding Adjustment in High-dimensional Covariate Spaces When Analyzing Healthcare Databases.
    Schneeweiss S; Eddings W; Glynn RJ; Patorno E; Rassen J; Franklin JM
    Epidemiology; 2017 Mar; 28(2):237-248. PubMed ID: 27779497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias.
    Suh HS; Hay JW; Johnson KA; Doctor JN
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):470-84. PubMed ID: 22461130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of propensity score technique to account for exposure-related covariates: an example and lesson.
    Seeger JD; Kurth T; Walker AM
    Med Care; 2007 Oct; 45(10 Supl 2):S143-8. PubMed ID: 17909373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of high-dimensional confounder summary scores in comparative studies of newly marketed medications.
    Kumamaru H; Gagne JJ; Glynn RJ; Setoguchi S; Schneeweiss S
    J Clin Epidemiol; 2016 Aug; 76():200-8. PubMed ID: 26931292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the high-dimensional propensity score for use with administrative data with propensity scores derived from high-quality clinical data.
    Austin PC; Wu CF; Lee DS; Tu JV
    Stat Methods Med Res; 2020 Feb; 29(2):568-588. PubMed ID: 30975044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confronting "confounding by health system use" in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment.
    Polinski JM; Schneeweiss S; Glynn RJ; Lii J; Rassen JA
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2(Suppl 2):90-8. PubMed ID: 22552984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of COPD Exacerbations Associated with Statins versus Fibrates: A New User, Active Comparison, and High-Dimensional Propensity Score Matched Cohort Study.
    Sun SH; Chang CH; Zhan ZW; Chang WH; Chen YA; Dong YH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2721-2733. PubMed ID: 34621122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential of High-Dimensional Propensity Scores in Health Services Research: An Exemplary Study on the Quality of Care for Elective Percutaneous Coronary Interventions.
    Enders D; Ohlmeier C; Garbe E
    Health Serv Res; 2018 Feb; 53(1):197-213. PubMed ID: 28093724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events.
    Helin-Salmivaara A; Lavikainen P; Aarnio E; Huupponen R; Korhonen MJ
    PLoS One; 2014; 9(3):e90325. PubMed ID: 24614626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariable confounding adjustment in distributed data networks without sharing of patient-level data.
    Toh S; Reichman ME; Houstoun M; Ding X; Fireman BH; Gravel E; Levenson M; Li L; Moyneur E; Shoaibi A; Zornberg G; Hennessy S
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1171-7. PubMed ID: 23878013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.